Lumos Diagnostics Holdings Limited is a healthcare company specializing in the development, manufacture, and commercialization of point-of-care diagnostic products designed to aid healthcare professionals in the rapid and accurate diagnosis and management of infectious diseases. With operations primarily in the United States and Australia, the company offers innovative diagnostic solutions such as FebriDx, a test capable of distinguishing between viral and bacterial respiratory infections, and ViraDx, a multi-test for influenza A, influenza B, and COVID-19. Founded in 2018 and headquartered in Carlsbad, California, Lumos Diagnostics focuses on delivering actionable, real-time diagnostic information that supports informed clinical decision-making and improved patient outcomes. Their product suite also includes disposable readers and handheld devices that facilitate point-of-care testing across diverse healthcare settings.